Countries North America
Merck and Abbisko Report Phase III Success for Pimicotinib in TGCT Treatment
Phase III MANEUVER study met primary endpoint, with an objective response rate at week 25 of 54.0% for pimicotinib versus 3.2% for placebo (p<0.0001) ...
November 27, 2024 | News
ReviR Therapeutics Secures Kennedy’s Disease Association Grant to Advance Therapy for Rare Neuromuscular Disorder
ReviR Therapeutics, a pioneering biotechnology company focused on developing novel small molecule RNA modulators for neurogenetic diseases, announced a gro...
November 26, 2024 | News
GC Biopharma and Novel Pharma Dose First US Patient in Pioneering Clinical Trial for Sanfilippo Syndrome Type A
GC Biopharma and Novel Pharma announced that the first patient in the US has been dosed in multinational clinical trial with 'GC1130A', an innovative new d...
November 26, 2024 | News
GE HealthCare Enhances OEC 3D C-Arm with Lung Suite and Expanded Interfaces for Advanced Bronchoscopy Imaging
To help improve clinician workflow and visualization during endoscopic bronchoscopy procedures, the company has added Lung Suite to their OEC 3D m-...
November 25, 2024 | News
Vaxxas Expands Global Patent Portfolio to 42, Securing Exclusive Rights to HD-MAP Vaccination Technology
-Vaxxas, a clinical-stage biotechnology company, has expanded its global intellectual property portfolio to 42 patents, supporting its exclusive claim to m...
November 25, 2024 | News
Boehringer Ingelheim Introduces VETMEDIN® Solution: A Liquid Option for Managing Canine Heart Failure
Heart disease in dogs is almost as common as it is in humans, affecting approximately 10 percent of dogs in their lifetime Previous studies have shown t...
November 25, 2024 | News
Sartorius Stedim Biotech Opens Center for Bioprocess Innovation in Massachusetts to Advance Next-Generation Therapeutics
New research labs and process development services to enable next generation therapeutics Up- and downstream process optimization, proof of concept runs...
November 22, 2024 | News
Kura Oncology and Kyowa Kirin Forge $1.5 Billion Global Partnership for Ziftomenib in AML Across U.S., Japan, and International Markets
Kura to receive a $330 million upfront payment and up to $1.2 billion in total milestone payments, including $420 million in ...
November 21, 2024 | News
GBI Biomanufacturing Expands Services with Automated Sterile Fill-Finish Capabilities
GBI Biomanufacturing (GBI), one of the world's longest serving contract development and manufacturing organizations (CDMO), is pleased to announce the expa...
November 21, 2024 | News
Laekna and Eli Lilly Partner to Accelerate Development of Innovative Obesity Treatment
Laekna, Inc. (2105.HK) ("Laekna"), a global biotech company focused on novel drug development for metabolic and cancer diseases, is pleased to announc...
November 21, 2024 | News
Alamar Biosciences and The Michael J. Fox Foundation Partner to Advance Parkinson's Biomarker Discovery
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is pleased to announce a strategic collaboration w...
November 20, 2024 | News
VelaVigo and Avenzo Therapeutics Join Forces to Develop Nectin4/TROP2 Bispecific ADC for Global Markets
VelaVigo Cayman Limited (VelaVigo), a biotech company focusing on discovery and development of multi-specific antibodies and antibody-drug conjugates...
November 19, 2024 | News
Biosion Secures $40M Upfront in Licensing Deal with Aclaris Therapeutics, with Milestones Exceeding $900M
Biosion receives over $40 million cash payment as upfront license fee and reimbursement for certain development costs & drug product materi...
November 19, 2024 | News
Zymo Research Files Antitrust Counterclaims Against Qiagen, Alleging Misuse of Litigation to Stifle Innovation
Zymo Research Corporation (Zymo Research), a leader in innovative life science solutions, announced today that it has filed claims in the United District C...
November 13, 2024 | News
Most Read
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
